Andrea Budgell

Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16 Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Canada's policy regarding the rules governing the legalization of marijuana

Seek amendments to the regulations and policies that govern the importation and exportation of medical cannabis. Elimination of the Health Canada annual 2.3% regulatory fee. Development of a framework to ensure consistent approach to the measurement and labeling of potency of cannabis products Amend the Excise Duty Framework for on Cannabis products to remove the $1.00 per gram duty with a 10% ad valorem rate. Amend the cannabis regulatory framework to permit cannabis licensed producers to more effectively communicate on the attributes of cannabis products with consumers. Amend the cannabis excise duty framework to eliminate the requirement that cannabis producers affix provincial / territory designated excise duty stamps to each individual package of cannabis, to be replaced by either a national excise duty stamp or a digital excise duty stamp.